{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:55:43Z","timestamp":1791309343574,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.opresp.2026.100668","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:19:27Z","timestamp":1788448767000},"page":"100668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Future Treatments for Tobacco Dependence"],"prefix":"10.1016","volume":"9","author":[{"given":"Carlos Andr\u00e9s","family":"Jimenez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Crist\u00f3bal Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"de Granda-Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ramos-Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"R\u00e1bade-Castedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Carrion-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Gorordo-Unzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Riesco-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2026.100668_bib0295","series-title":"Nuevas Perspectivas en el tratamiento del tabaquismo","article-title":"Individualizaci\u00f3n del tratamiento farmacol\u00f3gico del tabaquismo. Algoritmos, Aspectos cl\u00ednicos. Aspectos anal\u00edticos. Aspectos psicol\u00f3gicos. Aspectos evolutivos. Algoritmos de tratamiento farmacol\u00f3gico","author":"Jim\u00e9nez Ruiz","year":"2025"},{"key":"10.1016\/j.opresp.2026.100668_bib0300","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbres.2023.07.024","article-title":"Clinical practice guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on pharmacological treatment of tobacco dependence 2023","volume":"59","author":"R\u00e1bade-Castedo","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2026.100668_bib0305","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1164\/rccm.202005-1982ST","article-title":"Initiating pharmacologic treatment in tobacco-dependent adults: an official American Thoracic Society Clinical Practice Guideline","volume":"202","author":"Leone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0310","author":"Fiore","year":"2010"},{"key":"10.1016\/j.opresp.2026.100668_bib0315","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.opresp.2026.100668_bib0320","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"6","author":"Theodoulou","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.opresp.2026.100668_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107329","article-title":"The effect of Varenicline and Bupropion on smoking cessation: a network metaanalysis of 20 randomized controlled trials","volume":"131","author":"Guo","year":"2022","journal-title":"Addict Behav"},{"key":"10.1016\/j.opresp.2026.100668_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2026.100340","article-title":"Roles of synaptic cell adhesion molecules in the neuromodulatory systems","volume":"49","author":"Li","year":"2026","journal-title":"Mol Cells"},{"key":"10.1016\/j.opresp.2026.100668_bib0335","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","article-title":"Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking","volume":"13","author":"Berrettini","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.opresp.2026.100668_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118679","article-title":"Nicotinic acetylcholine receptors-targeting drug discovery","volume":"308","author":"Zhang","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.opresp.2026.100668_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108008","article-title":"Advances in the in vitro and in vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators","volume":"168","author":"Wilkerson","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.opresp.2026.100668_bib0350","article-title":"Understanding varenicline function via key receptor and ligand interactions","volume":"6","author":"Aiken","year":"2025","journal-title":"Cell Rep Phys Sci"},{"key":"10.1016\/j.opresp.2026.100668_bib0355","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/ntr\/ntab073","article-title":"A multicenter, double-blind, randomized, placebo-controlled phase 2b trial of cytisinicline in adult smokers (the ORCA-1 trial)","volume":"23","author":"Nides","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.opresp.2026.100668_bib0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jama.2023.10042","article-title":"Cytisinicline for smoking cessation: a randomized clinical trial","volume":"330","author":"Rigotti","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2026.100668_bib0365","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamainternmed.2025.0628","article-title":"Cytisinicline for smoking cessation: the ORCA phase 3 replication randomized clinical trial","volume":"185","author":"Rigotti","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.arbres.2025.08.002","article-title":"Analysis of effectiveness of clinical psychological care protocol for smoking cessation with cytisinicline","volume":"62","author":"Ramos-Pinedo","year":"2026","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2026.100668_bib0375","doi-asserted-by":"crossref","DOI":"10.2196\/76815","article-title":"Efficacy, safety, and economic impact of cytisinicline maintenance therapy in patients who are candidates for smoking cessation: protocol for a phase IV, multicenter, randomized, open-label controlled, parallel clinical trial (CITISILONG trial)","volume":"15","author":"Rabade Castedo","year":"2026","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.opresp.2026.100668_bib0380","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/add.14721","article-title":"Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation","volume":"114","author":"Tutka","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.opresp.2026.100668_bib0385","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1102035","article-title":"Placebo-controlled trial of cytisine for smoking cessation","volume":"365","author":"West","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0390","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thoraxjnl-2012-203035","article-title":"Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis","volume":"68","author":"Hajek","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.opresp.2026.100668_bib0395","doi-asserted-by":"crossref","first-page":"813","DOI":"10.33963\/KP.a2021.0025","article-title":"Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?","volume":"79","author":"Ramotowski","year":"2021","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.opresp.2026.100668_bib0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2021.7621","article-title":"Effect of cytisine vs varenicline on smoking cessation a randomized clinical trial","volume":"326","author":"Courtney","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2026.100668_bib0405","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1111\/add.15489","article-title":"Cytisine versus varenicline for smoking cessation in New Zealand indigenous M\u0101ori: a randomized controlled trial","volume":"116","author":"Walker","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.opresp.2026.100668_bib0410","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0893-133X(99)00086-X","article-title":"Effects on mood of acute phenylalanine\/tyrosine depletion in healthy women","volume":"22","author":"Leyton","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.opresp.2026.100668_bib0415","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.34172\/ahj.1538","article-title":"Pharmacokinetics of dual amino acids for dry powder inhalation therapy in pulmonary drug delivery: an in-vivo study","volume":"17","author":"Abinaya","year":"2025","journal-title":"Addict Health"},{"key":"10.1016\/j.opresp.2026.100668_bib0420","unstructured":"Citisiniclina en spray: ideal para los que no se sienten c\u00f3modos ingiriendo la presentaci\u00f3n en comprimidos. Available from: https:\/\/farmacosalud.com\/citisiniclina-en-spray-ideal-para-los-que-no-se-sienten-comodos-ingiriendo-la-presentacion-en-comprimidos\/Date. [Last Accessed 1 March 2026]."},{"key":"10.1016\/j.opresp.2026.100668_bib0425","unstructured":"Estudio observacional multic\u00e9ntrico de corte transversal para evaluar la efectividad, tolerabilidad, seguridad, adherencia y satisfacci\u00f3n de los pacientes usuarios de citisiniclina en el tratamiento del tabaquismo. Estudio Proteo."},{"key":"10.1016\/j.opresp.2026.100668_bib0430","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMoa1407764","article-title":"Cytisine versus nicotine for smoking cessation","volume":"371","author":"Walker","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40814-024-01591-4","article-title":"Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial","volume":"11","author":"Mir","year":"2025","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.opresp.2026.100668_bib0440","article-title":"Type-switching of short-acting nicotine replacement therapy products and its implications for treatment","volume":"160","author":"Veldhuizen","year":"2024","journal-title":"J Subst Use Addict Treat"},{"key":"10.1016\/j.opresp.2026.100668_bib0445","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ccr3.477","article-title":"Successful use of nicotine replacement therapy to quit e-cigarettes: lack of treatment protocol highlights need for guidelines","volume":"4","author":"Silver","year":"2016","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.opresp.2026.100668_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179173X211026676","article-title":"Electronic cigarette cessation in youth and young adults: a case series","volume":"14","author":"Sikka","year":"2021","journal-title":"Tobacco Use Insights"},{"key":"10.1016\/j.opresp.2026.100668_bib0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/pharmacy9010021","article-title":"Pilot study of electronic nicotine delivery systems (ENDS) cessation methods","volume":"9","author":"Sahr","year":"2021","journal-title":"Pharmacy"},{"key":"10.1016\/j.opresp.2026.100668_bib0460","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/10826084.2024.2320395","article-title":"Factors associated with successful e-cigarette cessation among a convenience sample of adult users","volume":"59","author":"Bejarano","year":"2024","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.opresp.2026.100668_bib0465","article-title":"Interventions for quitting vaping","volume":"1","author":"Butler","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.opresp.2026.100668_bib0470","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/add.16669","article-title":"Effect of nicotine mouth spray on urges to vape: a randomized, placebo-controlled, pharmacodynamic clinical trial in exclusive e-cigarette users","volume":"120","author":"Danielsson","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.opresp.2026.100668_bib0475","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026642","article-title":"Are dual users who smoke and use e-cigarettes interested in using varenicline to stop smoking altogether, and can they benefit from it? A cohort study of UK vapers","volume":"9","author":"Hajek","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.opresp.2026.100668_bib0480","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-023-02919-2","article-title":"Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial","volume":"21","author":"Caponnetto","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0485","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamainternmed.2024.1313","article-title":"Cytisinicline for vaping cessation in adults using nicotine e-cigarettes: the ORCA-V1 randomized clinical trial","volume":"184","author":"Rigotti","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0490","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.arbres.2025.07.018","article-title":"Consensus document SEPAR-AAMR-ALAT-ASONEUMOCITO-SMNCT on assessment and treatment for consumers of new tobacco and nicotine products","volume":"62","author":"R\u00e1bade-Castedo","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2026.100668_bib0495","first-page":"1","article-title":"Role of nicotine replacement therapy in the treatment of electronic cigarette users","volume":"27","author":"Jim\u00e9nez-Ruiz","year":"2025","journal-title":"Prev Tab"},{"key":"10.1016\/j.opresp.2026.100668_bib0500","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/resp.70066","article-title":"Thoracic Society of Australia and New Zealand (TSANZ) guidance for the management of electronic cigarette use (vaping) in adolescents and adults","volume":"30","author":"Marshall","year":"2025","journal-title":"Respirology"},{"key":"10.1016\/j.opresp.2026.100668_bib0505","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/npp.2015.114","article-title":"Increased functional connectivity in an insula-based network is associated with improved smoking cessation outcomes","volume":"40","author":"Addicott","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.opresp.2026.100668_bib0510","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12993-016-0100-5","article-title":"Chronic cigarette smoking is linked with structural alterations in brain regions showing acute nicotinic drug-induced functional modulations","volume":"12","author":"Sutherland","year":"2016","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.opresp.2026.100668_bib0515","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.1135926","article-title":"Damage to the insula disrupts addiction to cigarette smoking","volume":"315","author":"Naqvi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.opresp.2026.100668_bib0520","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1111\/add.15889","article-title":"Non-invasive brain stimulation for smoking cessation: a systematic review and meta-analysis","volume":"117","author":"Petit","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.opresp.2026.100668_bib0525","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3934\/Neuroscience.2024014","article-title":"Efficacy and safety of non-invasive brain stimulation techniques for the treatment of nicotine addiction: a systematic review of randomized controlled trials","volume":"11","author":"Iannuzzo","year":"2024","journal-title":"AIMS Neurosci"},{"key":"10.1016\/j.opresp.2026.100668_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2026.100611","article-title":"Combined use of pharmacological treatment and noninvasive brain stimulation for smoking cessation in adult smokers: a systematic review","volume":"8","author":"D\u00edaz-Miravalls","year":"2026","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.opresp.2026.100668_bib0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17425255.2021.1863948","article-title":"Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism","volume":"17","author":"Perez-Paramo","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.opresp.2026.100668_bib0540","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0545","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/17476348.2024.2429675","article-title":"Is the nicotine metabolite ratio a useful tool to improve the effectiveness, safety, and adherence to quitting smoking? Systematic review of the literature and meta-analysis","volume":"18","author":"de Granda-Orive","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.opresp.2026.100668_bib0550","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.opresp.2026.100668_bib0555","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuron.2011.04.013","article-title":"Aversion to nicotine is regulated by the balanced activity of \u03b24 and \u03b15 nicotinic receptor subunits in the medial habenula","volume":"70","author":"Frahm","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.opresp.2026.100668_bib0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102726","article-title":"12-Month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study","volume":"74","author":"De Giorgi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.opresp.2026.100668_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114565","article-title":"Targeting GLP-1 receptors to reduce nicotine use disorder: preclinical and clinical evidence","volume":"281","author":"Herman","year":"2024","journal-title":"Physiol Behav"},{"key":"10.1016\/j.opresp.2026.100668_bib0570","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1702448","article-title":"The potential role of GLP-1 receptor agonists in substance use disorders \u2013 a systematic review","volume":"16","author":"V\u00f6lker","year":"2026","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.opresp.2026.100668_bib0575","unstructured":"Xavier D., Alves G., de Oliveira I.B., Luis Geremias M., Brasil Xavier M. New research: GLP-1 receptor agonists may support nicotine cessation. Available from: https:\/\/www.psychiatry.org\/news-room\/news-releases\/new-research-glp-1-agonists-and-nicotine-cessation. [Last accessed 1 March 2026]."},{"key":"10.1016\/j.opresp.2026.100668_bib0580","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12020-026-04559-x","article-title":"GLP-1 receptor agonists and smoking cessation: therapeutic promise beyond glycemia","volume":"91","author":"Bhaduri","year":"2026","journal-title":"Endocrine"}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663626001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663626001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:41:13Z","timestamp":1791308473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663626001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":58,"alternative-id":["S2659663626001517"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2026.100668","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future Treatments for Tobacco Dependence","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2026.100668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100668"}}